Clinical trials of experimental Ebola treatment will start next month in West Africa as the regional death toll from the deadly virus surpasses 5,000.
One trial will treat infected patients with the antiviral drug brincidofovir at a medical center in the Liberian capital of Monrovia. In a second trial, patients will get the antiviral drug Favipiravir in the southern town of Gueckedou in Guinea. A third trial in the Guinean capital of Conakry will focus on giving patients blood transfusions from Ebola survivors, a method recommended by the World Health Organization.
Doctors Without Borders:
This is an unprecedented international partnership which represents hope for patients to finally get a real treatment against a disease that today kills between 50 and 80% of those infected.